Month: August 2024

Lima, Aug. 29, 2024 (GLOBE NEWSWIRE) — LIMA, Peru August 29, 2024 – Credicorp Ltd. (“Credicorp” or the “Company”) (NYSE: BAP | BVL: BAP), the leading financial services holding company in Peru with a presence in Chile, Colombia, Bolivia and Panama, announced today that its Board of Directors unanimously agreed to declare a special cash dividend of S/11.0000 per share for a total of S/1,038,205,487.00 in line with the Company´s Bye-Laws. Gianfranco Ferrari, Chief Executive Officer of Credicorp, stated, “This special dividend highlights the strength of our balance sheet and the significant strides in our strategic initiatives. We are advancing on investing in innovation and digital capabilities to meet our clients’ evolving needs while underscoring our commitment to rewarding shareholders.  We remain fully focused on executing our...

Vancouver, Canada, Aug. 29, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced the publication of its patent application under the international Patent Cooperation Treaty (“PCT”) for innovative combinations of Ketamine and N-Acylethanolamines. The patent application was filed as a result of the Company’s continuous collaboration with SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc”), a specialized pharmaceutical company in the clinical trial phase, dedicated to creating treatments for central nervous system disorders. As part of the collaboration, the two companies are researching combination therapies...

TEL AVIV, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (CSE: CMND) (FSE: CWY), a biotechnology company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, Clearmind has announced the publication of its patent application under the international Patent Cooperation Treaty, for innovative combinations of ketamine and N-acylethanolamines. SciSparc and Clearmind, as part of their collaboration, research combination...

HOUSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) — NASA has awarded Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, a $116.9 million contract to deliver six science and technology payloads, including one European Space Agency-led drill suite to the Moon’s South Pole. This award will leverage Intuitive Machines’ lunar delivery, data transmission, and autonomous operation capabilities to explore the region targeted for sustained human operations. “Over the last several years, we’ve witnessed NASA’s successful Artemis I mission and the campaign’s progress toward sustainably returning humans to the surface of the Moon, highlighting the importance of autonomous missions that advance humanity’s understanding of the Moon and the commercial services...

WARRENVILLE, Ill., Aug. 29, 2024 (GLOBE NEWSWIRE) — Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced that President & CEO Vince Arnone is scheduled to present at the 26th Annual H.C. Wainwright Global Investment Conference, taking place September 9-11, 2024 in New York City. Presentation Date & Time: September 10, 2024 at 12:00 pm Eastern Time. Live Webcast: Accessible on the Events section of Fuel Tech’s website at www.ftek.com and via the link here. A replay will be available for up to 90 days following the event. Mr. Arnone will also host one-on-one meetings with investors at the conference. To request a one-on-one meeting, please contact your H.C. Wainwright...